GlassScriptPhysician profile
Peter C Rodriguez
NPI 1225132764
$10,681.21
in general payments reported to CMS, 2019-2025
48 companies · $3,789 in 2025
The $3,789 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,377 · 2023: $2,140 · 2024: $3,375 · 2025: $3,789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,304.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,279.35 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,128.56 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $989.57 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Corcept Therapeutics | $772.24 | 2023-2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $751.66 | 2022-2025 | Jardiance, Synjardy, Tradjenta |
| Merck Sharp & Dohme LLC | $721.18 | 2022-2025 | Verquvo, Belsomra, Capvaxive |
| Abbvie INC. | $588.42 | 2022-2025 | |
| Glaxosmithkline, LLC. | $542.53 | 2022-2025 | Arexvy, Trelegy Ellipta |
| Otsuka America Pharmaceutical, INC. | $513.79 | 2022-2025 | Rexulti, Abilify Maintena |
| Gilead Sciences, INC. | $495.00 | 2023-2024 | Epclusa |
| Phathom Pharmaceuticals, INC. | $463.57 | 2024-2025 | Voquezna |
| Pfizer INC. | $212.24 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $172.74 | 2022-2023 | |
| Dexcom, INC. | $171.85 | 2024-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $165.40 | 2024-2025 | Recorlev |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.